pain drugs

Biotech

Biohaven pain spray aces test amid C-suite shake-up

Biohaven is eyeing filing for approval early next year for its experimental pain spray after data showed it hit its primary endpoints in a phase 3.
Ben Adams Dec 6, 2021 10:00am

Non-opioid pain drug indirectly blocks a key ion channel

Nov 10, 2021 2:00pm

Potential pain remedy emerges from 'junkyard of cancer drugs'

Oct 27, 2021 9:52am

Biogen's non-opioid painkiller offers mixed results in phase 2

Sep 16, 2021 9:55am

Allay Therapeutics rakes in $60M for 'tunable' pain treatment

Sep 15, 2021 10:27am

Bone Therapeutics' lead program flops in knee osteoarthritis

Aug 30, 2021 9:45am